Literature DB >> 23676604

Infective endocarditis caused by Enterococcus faecalis treated with continuous infusion of ampicillin without adjunctive aminoglycosides.

Taku Ogawa1, Masatoshi Sato, Shinsuke Yonekawa, Chiyo Nakagawa, Kenji Uno, Kei Kasahara, Koichi Maeda, Mitsuru Konishi, Keiichi Mikasa.   

Abstract

Aminoglycosides are useful antimicrobial agents for treating infective endocarditis; however, they occasionally cause troublesome side effects, such as nephrotoxicity and ototoxicity. We herein report a case of infective endocarditis caused by Enterococcus faecalis that was treated successfully with continuous infusion of ampicillin without adjunctive aminoglycosides. The serum ampicillin concentrations were higher than the minimal inhibitory concentration for the target strain. Although the use of ampicillin monotherapy is currently avoided because double β-lactam therapy is reportedly more effective, continuous penicillin administration remains an effective therapeutic choice for treating infective endocarditis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23676604     DOI: 10.2169/internalmedicine.52.8425

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Is an aminoglycoside still required for the treatment of enterococcal endocarditis?

Authors:  Donald P Levine
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 2.  Pulp revascularization of immature permanent teeth: a review of the literature and a proposal of a new clinical protocol.

Authors:  Mélanie Namour; Stephanie Theys
Journal:  ScientificWorldJournal       Date:  2014-10-14

3.  A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis.

Authors:  Milo Gatti; Sara Tedeschi; Filippo Trapani; Stefania Ramirez; Rita Mancini; Maddalena Giannella; Pierluigi Viale; Federico Pea
Journal:  Antibiotics (Basel)       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.